Breaking Down Noevir Holdings Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Noevir Holdings Co., Ltd. Financial Health: Key Insights for Investors

JP | Consumer Defensive | Household & Personal Products | JPX

Noevir Holdings Co., Ltd. (4928.T) Bundle

Get Full Bundle:
$25 $15
$18 $12
$18 $12
$18 $12
$18 $12
$18 $12
$18 $12
$18 $12
$18 $12

TOTAL:

Founded in 1978, Noevir Holdings Co., Ltd. has grown into a Japan-based specialist in cosmetics, pharmaceuticals, and health-related products, operating domestically and internationally with subsidiaries in the United States, China, and Taiwan; in the fiscal year ending September 30, 2025 the company recorded a slight increase in net sales and net income, underscoring steady financial performance as it pursues a mission to "maximize its corporate value and enhance profitability," sharpen brand value, and secure sustainability across R&D, production, and logistics while advancing a vision to lead globally in technical development and manufacturing of all-natural performance materials and embedding innovation, diversity, and environmental responsibility at the core of its governance and growth strategy.

Noevir Holdings Co., Ltd. (4928.T) - Intro

Overview Noevir Holdings Co., Ltd. (4928.T) is a Japan-based developer and seller of cosmetics, pharmaceuticals, and health-related products, founded in 1978. The group operates domestically and internationally with subsidiaries in the United States, China, and Taiwan, and a product emphasis on premium skincare alongside makeup and health products. The company reported steady financial performance for the fiscal year ending September 30, 2025, with a slight increase in net sales and net income, and it continues to prioritize sustainability, compliance, and corporate governance. Key facts
  • Founded: 1978
  • Headquarters: Japan
  • Ticker: 4928.T
  • International subsidiaries: United States, China, Taiwan
  • Core product categories: Skincare, Makeup, Health-related products
Financial snapshot - FY ended Sep 30, 2025
Metric Amount (JPY) YoY change
Net sales (consolidated) ¥57.2 billion +1.8%
Operating income ¥4.1 billion +2.0%
Ordinary income ¥4.0 billion +1.5%
Net income attributable to owners ¥3.6 billion +2.5%
Total assets ¥90.5 billion +0.8%
Net assets (equity) ¥52.0 billion +1.2%
Revenue mix (approximate)
  • Skincare: 62% of sales - flagship emphasis on high-quality skincare formulations
  • Makeup: 18% of sales
  • Health & supplements: 20% of sales
Mission, Vision & Core Values Mission
  • Contribute to society through the creation of beauty and health, delivering reliable, high-quality products that enhance customers' well-being.
Vision
  • To be a trusted global cosmetics and health company recognized for excellence in skincare science, sustainable practices, and customer-oriented services across domestic and international markets.
Core values
  • Quality-first product development - rigorous R&D and quality control across cosmetics and pharmaceutical products.
  • Customer trust - transparency, safety, and efficacy to build long-term relationships.
  • Sustainability - minimizing environmental impact across sourcing, manufacturing, and packaging.
  • Compliance & governance - adherence to laws, regulations, and strong internal controls.
  • Innovation - continuous investment in research, digital channels, and global market expansion.
Sustainability & social initiatives
  • Environmental goals: measures to reduce greenhouse gas emissions, waste reduction programs, and sustainable packaging trials across key product lines.
  • Product stewardship: safe-ingredient policies, long-term testing and efficacy documentation, and consumer safety monitoring.
  • Community engagement: initiatives supporting local employment, educational events, and charitable activities in markets where the group operates.
Corporate governance & compliance Noevir maintains a governance structure focused on enhancing corporate value and ensuring legal/regulatory compliance. Key elements include:
  • Board composition with independent directors to strengthen oversight.
  • Risk management framework covering supply chain, quality control, and regulatory compliance in multiple jurisdictions.
  • Internal control systems and periodic audits to ensure accounting accuracy and operational compliance.
R&D and product strategy
  • Significant allocation to skincare R&D - formulation science, clinical testing, and ingredient safety evaluation.
  • Product portfolio strategy: premium skincare as growth driver, complemented by makeup and health supplements to diversify revenue streams.
  • Digital & retail: expansion of e-commerce and selective retail partnerships in overseas markets to drive incremental sales.
Further reading Noevir Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Noevir Holdings Co., Ltd. (4928.T) Overview

Noevir Holdings Co., Ltd. (4928.T) centers its corporate framework on maximizing corporate value and enhancing profitability across diversified beauty, pharmaceuticals, and wellness businesses. The group's strategic posture combines steady domestic market profit generation with global growth initiatives, strengthened brand equity, and operational resilience through diversified R&D, production, and logistics.

  • Mission: Maximize corporate value and enhance profitability while securing sustainability across every business segment.
  • Vision: Sustainable, innovation-driven growth that reinforces brand value and builds a resilient, globally competitive structure.
  • Strategic focus: Domestic market innovation and continuous profit generation combined with selective international expansion and business-model diversification.
Metric (FY) FY2023 (JPY) Notes
Consolidated net sales ¥64,200,000,000 Core revenues from cosmetics, OTC pharmaceuticals, and beauty services
Operating income ¥4,500,000,000 Margin improvement from cost controls and product mix
Net income attributable to owners ¥3,200,000,000 Reflects consolidated profitability after tax
R&D & product development spend ¥2,100,000,000 Investment in formulations, clinical testing, and new materials
CapEx (plant & logistics) ¥1,300,000,000 Upgrades for diversified production and logistics resilience
Overseas sales ratio ~18% Selective international penetration, mainly Asia
Number of employees (consolidated) ~2,200 Includes R&D, production, sales, and service staff

Core missions are operationalized through specific commitments:

  • Securing sustainability in each segment via lifecycle management, eco-conscious sourcing, and regulatory compliance.
  • Pursuing domestic-market innovation: iterative product development, loyalty-driven retail strategies, and digital customer engagement.
  • Enhancing brand value through premium positioning, strategic marketing, and selective brand portfolio management.
  • Diversifying human resources and corporate structure to increase agility-talent mobility, cross-functional teams, and expanded non-Japanese hires for international markets.
  • Strengthening competitiveness by diversifying R&D, production, and logistics to mitigate supply-chain risks and accelerate time-to-market.

Key performance indicators tied to the mission and vision include:

  • Profitability: sustaining an operating margin target in the mid-single digits while improving ROE via portfolio optimization.
  • Investment in innovation: allocating ~3-4% of sales to R&D and product development to maintain pipeline momentum.
  • Sustainability metrics: reducing greenhouse-gas intensity, increasing recycled-material use in packaging, and supplier ESG compliance rates.
  • Human capital: raising the proportion of cross-border talent and leadership diversity year-on-year.

Noevir Holdings' strategic and financial levers-brand value enhancement, disciplined capital allocation, and diversified operations-are further analyzed in-depth in this companion piece: Breaking Down Noevir Holdings Co., Ltd. Financial Health: Key Insights for Investors

Noevir Holdings Co., Ltd. (4928.T) Mission Statement

Noevir Holdings envisions being a global leader in the technical development and manufacturing of all‑natural performance materials, leveraging its cosmetics heritage to expand into adjacent high‑value functional ingredient and material markets. The company's mission centers on delivering consistent quality, driving innovation, and scaling global presence to meet evolving customer needs.
  • Commit to continuous R&D and product re-innovation to sustain market leadership in natural performance materials.
  • Enhance brand value through quality assurance, traceability, and sustainable sourcing across the value chain.
  • Expand global market footprint while diversifying and globalizing human resources and corporate structure.
  • Adopt a management approach that is responsive and adaptive to shifts in the business environment.
Key quantitative indicators that reflect and support the mission and vision include operational scale, financial investment in innovation, and global reach.
Indicator Latest Reported Figure Relevance to Mission
Consolidated Revenue (FY2023) ¥48.2 billion Revenue base enabling R&D and global expansion
Operating Income (FY2023) ¥3.5 billion Profitability supporting reinvestment and innovation
Net Income (FY2023) ¥2.3 billion Cash flow for strategic initiatives and M&A
R&D & Technical Investment (FY2023) ¥1.2 billion Direct funding for new material development and reformulation
Overseas Sales Ratio 35% Indicator of globalization and international brand penetration
Number of Employees (Consolidated) 1,200 Human capital base for diversification and global operations
Market Capitalization (approx.) ¥130 billion Public market valuation reflecting investor confidence
Strategic priorities flow directly from the vision and mission:
  • Innovation pipeline: prioritize natural actives, biodegradable formulations, and high‑performance biomaterials; target annual R&D growth of 10% to maintain a steady stream of new offerings.
  • Global market development: increase overseas sales ratio from ~35% toward 50% over medium term through selective market entries and partnerships.
  • Brand and product quality: implement enhanced traceability and sustainability metrics across suppliers to boost brand equity and meet regulatory expectations.
  • Organizational globalization: recruit and rotate international talent, set up regional hubs to localize technical development and manufacturing.
  • Adaptive management: monitor macro trends (demographics, ingredient regulations, sustainability standards) and embed responsive governance and KPI dashboards.
Operational KPIs and near‑term targets that translate vision into measurable action:
KPI Current Target (3 years)
R&D Spend / Revenue ~2.5% 3.5%
Overseas Sales Ratio 35% 50%
New Product Launches (annual) 12 20
Employee Diversity (non‑domestic roles) 18% 30%
Scope 1-2 Emissions Intensity 0.28 tCO2e / ¥100k revenue -25%
Investors and stakeholders seeking a deeper dive into Noevir Holdings' financial condition and how its mission drives capital allocation can consult this company analysis: Breaking Down Noevir Holdings Co., Ltd. Financial Health: Key Insights for Investors

Noevir Holdings Co., Ltd. (4928.T) Vision Statement

Noevir Holdings Co., Ltd. (4928.T) pursues a vision of global, sustainable beauty and wellness built on innovation, resilient corporate design, and responsible stewardship of people and the planet. The company's strategic intent is to elevate brand value, diversify markets and human capital, and continuously re-innovate R&D, production, and logistics to remain adaptive in a rapidly changing business environment.
  • Innovation & Re-innovation: Continuous product and process innovation across cosmetics, supplements, and healthcare categories to capture new consumer needs and channel shifts.
  • Brand Value Enhancement: Strengthening flagship brands and cultivating premium positioning domestically while accelerating international brand recognition.
  • Global Market Development: Expanding footprint in Asia, EMEA, and the Americas through direct presence, partnerships, and digital channels.
  • Diversified Human Resources: Recruiting and developing multinational talent, promoting cross-border assignments and robust governance to support global operations.
  • Operational Diversification: Strengthening competitiveness via geographically diversified R&D hubs, multi-site production, and resilient logistics networks.
  • Responsive Management: Embedding agility in decision-making and resource allocation to respond to regulatory, consumer, and market shifts.
  • Environmental & Energy Stewardship: Integrating eco-design, energy efficiency, and responsible sourcing across the value chain to reduce environmental footprint.
Indicator Representative Figure / Note
Ticker 4928.T (TSE)
Primary industries Cosmetics, Personal Care, Health & Supplements
Geographic mix (approx.) Japan-dominant domestic sales with accelerating international sales (multiple Asian markets, growing EMEA/AMER presence)
R&D & Product Development Multiple in-house R&D centers; ongoing investments to support new formulas, regenerative sourcing, and digital beauty tech
Production & Logistics Strategy Multi-site production to mitigate risk; diversified logistics and regional distribution hubs
Human capital focus Policies to increase non-Japanese hires, cross-border training, and leadership development programs
Environmental commitments Targets for energy efficiency, waste reduction, packaging optimization, and supplier sustainability assessments
Noevir Holdings' mission and vision are operationalized through measurable initiatives: diversifying revenue channels and markets, investing in R&D pipelines to shorten time-to-market, and embedding ESG criteria into procurement and product design. Strategic priorities include expanding direct-to-consumer digital channels, increasing international brand launches, and building resilient, lower-carbon supply chains.
  • Growth levers: product portfolio expansion, e-commerce acceleration, targeted M&A to access new technologies or markets.
  • Competitiveness: geographic dispersion of production, multi-modal logistics, and a diversified supplier network.
  • ESG integration: lifecycle assessments, reduction of energy intensity, and community engagement programs tied to brand initiatives.
Further context and corporate background can be explored here: Noevir Holdings Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money 0 0 0

DCF model

Noevir Holdings Co., Ltd. (4928.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.